Clinical trial
Phase II Trial Of Induction Chemotherapy Followed By Attenuated Chemoradiotherapy For Locally Advanced Head And Neck Squamous Cell Carcinoma Associated With Human Papillomavirus (HPV)
NCT02048020 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial Of Induction Chemotherapy Followed By Attenuated Chemoradiotherapy For Locally Advanced Head And Neck Squamous Cell Carcinoma Associated With Human Papillomavirus (HPV)
- Lead sponsor
- Jonsson Comprehensive Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 26, 2013
- Completion date
- January 9, 2017
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human papilloma virus infection, stage iii squamous cell carcinoma of the hypopharynx, stage iii squamous cell carcinoma of the larynx, stage iii squamous cell carcinoma of the oropharynx, stage iii verrucous carcinoma of the larynx, stage iv squamous cell carcinoma of the hypopharynx, stage iv verrucous carcinoma of the larynx, stage iva squamous cell carcinoma of the larynx, stage iva squamous cell carcinoma of the oropharynx, stage iva verrucous carcinoma of the larynx, stage ivb squamous cell carcinoma of the larynx, stage ivb squamous cell carcinoma of the oropharynx, stage ivb verrucous carcinoma of the larynx, stage ivc squamous cell carcinoma of the larynx, stage ivc squamous cell carcinoma of the oropharynx, stage ivc verrucous carcinoma of the larynx